Wedbush Trims Biogen (NASDAQ:BIIB) Target Price to $213.00
Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by Wedbush from $245.00 to $213.00 in a report released on Wednesday morning, Benzinga reports. Wedbush currently has a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q1 2024 earnings at $3.25 EPS, Q3 2024 earnings at $4.13 EPS, Q4 […]
More Stories
Raymond James Boosts Amazon.com (NASDAQ:AMZN) Price Target to $205.00
Amazon.com (NASDAQ:AMZN) had its target price upped by Raymond James from $200.00 to $205.00 in a research report issued on...
Evercore ISI Raises Amazon.com (NASDAQ:AMZN) Price Target to $225.00
Amazon.com (NASDAQ:AMZN) had its price objective boosted by equities researchers at Evercore ISI from $220.00 to $225.00 in a research...
The Goldman Sachs Group Increases Amazon.com (NASDAQ:AMZN) Price Target to $225.00
Amazon.com (NASDAQ:AMZN) had its target price hoisted by research analysts at The Goldman Sachs Group from $220.00 to $225.00 in...
Starbucks (NASDAQ:SBUX) Price Target Lowered to $84.00 at Jefferies Financial Group
Starbucks (NASDAQ:SBUX – Get Free Report) had its target price lowered by equities research analysts at Jefferies Financial Group from...
Starbucks (NASDAQ:SBUX) PT Lowered to $92.00
Starbucks (NASDAQ:SBUX – Get Free Report) had its price target reduced by analysts at Evercore ISI from $120.00 to $92.00...
Actor Lee Seo Han Apologises For Uploading An Obscene Video on Instagram
On Thursday, May 2, 2024, famous Korean actor, Lee Seo Han, posted a video on his Instagram account with the...